Smarter Drug Discovery: Turning Screening Hits into Opportunities

Harder, better, faster, stronger – or maybe simply Smarter!

Finding screening hits is a milestone for any company, but the journey to a finished drug is still long. Knowing how to navigate upcoming decisions in an efficient way, and where to focus your efforts at this early stage, is crucial for the success of your project. What can make this even trickier is that resources are often limited, and the team involved can be quite lean. Still, the fight is far from lost and with just a bit of knowledge the project can make it through many such limitations. We know a thing or two about this, and we are happy to share.

On November 5, at 5 pm CET (Stockholm), you can join our very own Björn Borgström for Smarter Drug Discovery: Turning Screening Hits into Opportunities, a webinar featuring over a decade of experience and practical case studies. Björn has been involved in several projects throughout his RG Discovery years, and among other things he will talk about creative approaches to getting early discovery projects moving, efficient hit identification for CDK9 and SMARCA4, and using CETSA-based selectivity profiling to spot potential liabilities and new opportunities early.

If you have any role in early drug discovery, we believe this session is for you – hope to see you there!

Back